Trial Profile
Pharmacokinetic properties of fondaparinux sodium in morbidly obese volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- 15 May 2008 Status changed from recruiting to completed, reported by ClinicalTrials.gov.
- 22 Mar 2007 New trial record.